Remission induction with the original program with a variety of different programs to strengthen the treatment of acute myeloid leukemia efficacy of.doc

 PAGE \* MERGEFORMAT 11 Remission induction with the original program with a variety of different programs to strengthen the treatment of acute myeloid leukemia efficacy of Study: Xian Yin recorded, Li Jing, Yao Wei, Wang Jing, Lorry [Abstract] Objective: To investigate the acute myeloid leukemia (AML) remission induction of appropriate intensive treatment program. Methods: 37 patients with AML were randomly divided into groups and a variety of programs the original proposal group, in addition to recurrence, the intensive treatment were 1 to 2 years. the original regimen induced remission by the original program (DA or MA, the original remission induction chemotherapy and etoposide or teniposide or homoharringtonine base, the original program in the induction of remission by the conventional dose Ara-C to or high-dose chemotherapy and other alternative programs, a variety of programs, or high-dose group were Ara, HA, HAE, DA, DAE, MA, MAE, AA and other programs used alternately with solutions in which the original application of 2 to induce remission 3 courses. Results: The program group and a variety of programs in patients 1 year disease free survival (DFS rates were 76.5% and 70% (Pgt; 0.05,3 years DFS rates were 46.7% and 12.5% #8203;#8203;(P lt;0.05 . Conclusion: The method with repeated induction of remission intensive therapy program AML, long-term efficacy is superior to alternative treatment for a variety of different options program. [Keywords:] leukemia, myeloid, acute, drug therapy, intensive treatment, disease-free survival Patients with acute leukemia long-term survival is the key to therapeutic strategies properly formulated. Of non-hematopoietic stem cell transplantation in patients with complete remission (CR after consolidation of intensive treatment is its long-term survival of an important part, the different post-remission treatment and dose intensity the impact on patient survival has been one of the hot spots. the prevailing v